Giddings Pharmaceutical Company is a maker of drugs for high blood pressure and uses a process costing system. The following information pertains to the final department of Giddings's blockbuster drug called Solcax.

Beginning work-in-process (40% completed)625units

Transferred-in3,300units

Normal spoilage365units

Abnormal spoilage165units

Good units transferred out2,900units

Ending work-in-process (1/3 completed)495units

Conversion costs in beginning inventory$3,147

Current conversion costs$6,200

Giddings calculates separate costs of spoilage by computing both normal and abnormal spoiled units. Normal spoilage costs are reallocated to good units and abnormal spoilage costs are charged as a loss. The units of Solcax that are spoiled are the result of defects not discovered before inspection of finished units. Materials are added at the beginning of the process. Using the weighted-average method, answer the following question:

What are the total conversion costs in ending inventory?